Business · 30/10/2015Updated: 10/17/2026 · 1 min read
FDA Releases Revised Draft Guidance for Liposome Drug Products
The FDA has made a revised draft guidance document available for industry, updating recommendations for chemistry, manufacturing, and controls, pharmacokinetics and bioavailability, and labeling for liposome drug products submitted in new drug applications and other FDA reviews.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →